Skip to content
← Full study record

NCT00931528 · BASELINE

Baseline characteristics

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy · Source last updated 2018-02-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      112
    2. group Id
      BG001
      value
      109
    3. group Id
      BG002
      value
      221
    units
    Participants
groups
  1. description
    Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil 5mg once daily for 24 weeks.
    id
    BG000
    title
    Tadalafil
  2. description
    Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          45
          upper Limit
          80
          value
          63
        2. group Id
          BG001
          lower Limit
          48
          upper Limit
          79
          value
          63
        3. group Id
          BG002
          lower Limit
          45
          upper Limit
          80
          value
          63
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          112
        2. group Id
          BG001
          value
          109
        3. group Id
          BG002
          value
          221
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
All randomized eligible patients.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      112
    2. group Id
      BG001
      value
      109
    3. group Id
      BG002
      value
      221
    units
    Participants
groups
  1. description
    Beginning ≤ 7 days after the start of radiotherapy, patients receive oral tadalafil 5mg once daily for 24 weeks.
    id
    BG000
    title
    Tadalafil
  2. description
    Beginning ≤ 7 days after the start of radiotherapy, patients receive oral placebo once daily for 24 weeks.
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          45
          upper Limit
          80
          value
          63
        2. group Id
          BG001
          lower Limit
          48
          upper Limit
          79
          value
          63
        3. group Id
          BG002
          lower Limit
          45
          upper Limit
          80
          value
          63
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          112
        2. group Id
          BG001
          value
          109
        3. group Id
          BG002
          value
          221
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
All randomized eligible patients.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice